Suman Rohilla

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Emerging Applications of Plant Antimicrobials in the Food Industry
  Current Pharmaceutical Biotechnology 2025 DOI: 10.2174/0113892010310982240613055746
  +Save
• Computer-aided Drug Design for Alzheimer's Disease: Recent Advancements and Future Perspectives
  Current Topics in Medicinal Chemistry 2025 DOI: 10.2174/0115680266343814250713100224
  +Save
• Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates
  Current Drug Discovery Technologies 2024 DOI: 10.2174/0115701638295739240222074426
  +Save
• A Review on Indole-triazole Molecular Hybrids as a Leading Edge in Drug Discovery: Current Landscape and Future Perspectives
  Current Topics in Medicinal Chemistry 2024 DOI: 10.2174/0115680266307132240509065351
  +Save
• Uncovering the complex role of interferon-gamma in suppressing type 2 immunity to cancer
  Cytokine 2023 DOI: 10.1016/j.cyto.2023.156376
  +Save
• Piperidine Nucleus as a Promising Scaffold for Alzheimer’s Disease: Current Landscape and Future Perspective
  Current Topics in Medicinal Chemistry 2023 DOI: 10.2174/1568026623666230406084315
  +Save
• Exploring the Mechanical Perspective of a New Anti-Tumor Agent: Melatonin
  Journal of Environmental Pathology, Toxicology and Oncology 2023 DOI: 10.1615/jenvironpatholtoxicoloncol.2022042088
  +Save
• Recent Developments and Challenges in Molecular-Targeted Therapy of Non-Small-Cell Lung Cancer
  Journal of Environmental Pathology, Toxicology and Oncology 2023 DOI: 10.1615/jenvironpatholtoxicoloncol.2022042983
  +Save
• Sulfonamides, quinolones, antiseptics, and disinfectants
  Medicinal Chemistry of Chemotherapeutic Agents 2023 DOI: 10.1016/b978-0-323-90575-6.00015-6
  +Save
• A New Series of 1,3-Dimethylxanthine Based Adenosine A2A Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinson’s Disease
  Current Drug Discovery Technologies 2021 DOI: 10.2174/1570163817666200827112252
  +Save